MyWoundDoctor, an innovative provider of virtual tech-enabled wound care services offered through a patent- pending AI-based process, announced today a Series B investment from Claritas Capital, a Nashville-based private equity firm.
The U.S. healthcare system spends in excess of $60 billion per year on wound care as it treats more than 8 million patients. MyWoundDoctor addresses rising cost and quality issues by providing caregivers and patients with evidence-based wound care treatment and personalized supplies initiated through an easy-to-use telehealth mobile imaging application. The Claritas investment will enable MyWoundDoctor to scale its business, expand into new markets, and enhance its technology infrastructure which includes additional artificial intelligence functionality.
"Wound care is a significant cost and quality issue within the American healthcare system," said Dan Heneghan, chief executive officer, MyWoundDoctor. "This investment from Claritas will help us scale our operations so that we can deliver expertise directly to patients anywhere, reducing their wound care costs as we improve both outcomes and quality of life."
"Virtual care is modernizing and expanding access to care for patients, and MyWoundDoctor's top-notch remote wound care specialists deliver highly effective, affordable, and convenient wound care," said Tania Grant, principal, Claritas Capital. "We are excited to partner with MyWoundDoctor to ensure that every patient receives the effective wound care that they need to heal."